UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054442
Receipt number R000062189
Scientific Title Evaluation of Relaxation Effect by Periocular Thermal Stimulation
Date of disclosure of the study information 2024/05/31
Last modified on 2024/11/20 09:04:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of Relaxation Effect by Eye Mask

Acronym

Evaluation of Relaxation Effect by Eye Mask

Scientific Title

Evaluation of Relaxation Effect by Periocular Thermal Stimulation

Scientific Title:Acronym

Evaluation of Relaxation Effect by Thermal Stimulation

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the relaxing effect of wearing an eye mask

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of alpha and theta waves when wearing an eye mask

Key secondary outcomes

-autonomic nervous system activity
-skin temperature change


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Wear the test product eye mask >Washout for more than 1week >Wear a comparative eye mask >Washout for more than 1 week >Wear a control eye mask
(Eye mask wearing time is 30 minutes)

Interventions/Control_2

Wear a comparative eye mask >Washout for more than 1week >Wear the test product eye mask >Washout for more than 1week > Wear a control eye mask
(Eye mask wearing time is 30 minutes)

Interventions/Control_3

Wear a control eye mask >Washout for more than 1week >Wear a comparative eye mask >Washout for more than 1week > Wear the test product eye mask
(Eye mask wearing time is 30 minutes)

Interventions/Control_4

Wear the test product eye mask >Washout for more than 1week >Wear a control eye mask >Washout for more than 1 week >Wear a comparative eye mask
(Eye mask wearing time is 30 minutes)

Interventions/Control_5

Wear a comparative eye mask >Washout for more than 1week >Wear a control eye mask >Washout for more than 1week >Wear the test product eye mask
(Eye mask wearing time is 30 minutes)

Interventions/Control_6

Wear a control eye mask >Washout for more than 1week >Wear the test product eye mask >Washout for more than 1week >Wear a comparative eye mask
(Eye mask wearing time is 30 minutes)

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

1. Healthy female aged 20-59
2. Person who has experience with eye masks

Key exclusion criteria

1.Person who has some problems due to eye mask use
2.Person who sleep less than 5 hours on average
3.Person who are sensitive to alcohol wipes or sticker application
4.Person who plan to participate in other studies
5.Person who deemed inappropriate by the principal investigator

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Kyoko
Middle name
Last name Tagami

Organization

Kao Corporation

Division name

Human Health Care Research Lab.

Zip code

1318501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7271

Email

tagami.kyouko@kao.com


Public contact

Name of contact person

1st name Aoi
Middle name
Last name Ishikawa

Organization

Kao Corporation

Division name

Human Health Care Research Lab.

Zip code

1318501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7271

Homepage URL


Email

ishikawa.aoi@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

25

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 05 Month 09 Day

Date of IRB

2024 Year 05 Month 09 Day

Anticipated trial start date

2024 Year 05 Month 27 Day

Last follow-up date

2024 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2024 Year 05 Month 21 Day

Last modified on

2024 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062189